Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Am J Public Health. 2018 Aug 23;108(10):1394–1400. doi: 10.2105/AJPH.2018.304590

Table 2. Effects of Individual Interventions over Ten Years.

Mean Changea Compared to the Status Quo
Intervention Discounted Net Present LYsb in Thousands (%) Discounted Net Present QALYsb in Thousands (%) Pill Deaths (%) Heroin Deaths (%) Total Opioid Deaths (%)
Acute Pain Prescribing 500 (0.007%) −450 (−0.007%) −6,100 (−3.6%) −1,900 (−0.6%) −8,000 (−1.6%)
Prescribing for Transitioning Pain 80 (0.001%) 180 (0.003%) −2,600 (−1.5%) 1,500 (0.5%) −1,000 (−0.2%)
Chronic Pain Prescribing 40 (0.001%) 670 (0.010%) −24,400 (−14.2%) 28,200 (8.2%) 3,800 (0.7%)
Drug Rescheduling −920 (−0.014%) 990 (0.015%) −103,800 (−60.7%) 146,600 (42.8%) 42,800 (8.3%)
PMP −1,780 (−0.027%) −1,450 (−0.022%) −47,800 (−28.0%) 90,200 (26.3%) 42,300 (8.2%)
Drug Reformulation 650 (0.010%) 2,000 (0.030%) −43,300 (−25.3%) 39,400 (11.5%) −3,900 (−0.8%)
Excess Opioid Disposal 210 (0.003%) 510 (0.008%) −7,900 (−4.6%) 5,500 (1.6%) −2,400 (−0.5%)
Naloxone Availability 790 (0.012%) 670 (0.010%) −8,400 (−4.9%) −12,700 (−3.7%) −21,200 (−4.1%)
Needle Exchange 210 (0.003%) 180 (0.003%) 0 (0.0%) −5,900 (−1.7%) −5,900 (−1.1%)
MAT 560 (0.008%) 940 (0.014%) −2,900 (−1.7%) −9,600 (−2.8%) −12,500 (−2.4%)
Psychosocial Treatment 440 (0.007%) 650 (0.010%) −1,600 (−0.9%) −6,000 (−1.7%) −7,500 (−1.5%)

Abbreviations: MAT = medication-assisted treatment; PMP = prescription monitoring program

a

Ranges over the ten base cases are shown in Appendix Table 8.

b

Discounted to 2016.